Home telemonitoring effectiveness in COPD: a systematic review by Cruz, Joana et al.
HOME TELEMONITORING IN COPD 
1 
 
Title: Home telemonitoring effectiveness in COPD: a systematic review  
 
Joana Cruza PT MSc, Dina Brooksb PT MSc PhD, Alda Marquesc PT MSc PhD 
aDepartment of Health Sciences (SACS), University of Aveiro, Aveiro, Portugal 
bGraduate Department of Rehabilitation Science, Department of Physical Therapy, 
University of Toronto, Toronto, Canada 
cSchool of Health Sciences, University of Aveiro (ESSUA), Aveiro, Portugal; Unidade de 
Investigação e Formação sobre Adultos e Idosos (UniFAI), Porto, Portugal 
 
Corresponding author: 
Alda Marques 
School of Health Sciences of the University of Aveiro (ESSUA),  
Campus Universitário do Crasto, Edifício 30, 3810-193 Aveiro, Portugal.  
Telephone: 00351 234 372 462 
Email: amarques@ua.pt  
 
Disclosures: None 
 
Running head: HOME TELEMONITORING IN COPD 
 
Word count (abstract): 240 
Word count (text only): 3280 
Tables: 2 
Figures: 3 
HOME TELEMONITORING IN COPD 
2 
 
Abstract 
Objectives: To provide a systematic review of the effectiveness of home telemonitoring 
to reduce healthcare utilisation and improve health-related outcomes of patients with 
COPD. 
Methods: An electronic literature search in Medline, Embase, B-on and Web of Science 
was conducted from June to August 2012 and updated until July 2013, using the 
following keywords: [tele(-)monitoring or tele(-)health or tele(-)homecare or tele(-)care 
or tele-home health or home monitoring] and [Chronic Obstructive Pulmonary Disease or 
COPD]. Randomised and non-randomised controlled trials evaluating home 
telemonitoring interventions in COPD were included. A meta-analysis using risk ratio 
(RR) and standardised mean difference (SMD) was conducted for healthcare utilisation 
(hospitalisations, length of stay, emergency department visits) and associated costs, and 
health-related outcomes (mortality, exacerbations and health-related quality of life 
(HRQOL)). 
Results: Nine articles were included. Significant differences were found for 
hospitalisation rates (RR=0.72; 95%CI=0.53-0.98; p=0.034); however, no differences in 
the other healthcare utilisation outcomes were observed. There was a trend to reduced 
healthcare costs in the telemonitoring group. In two studies, this intervention was 
associated with a reduced number of exacerbations (p<0.05) and a significant increase in 
HRQOL (SMD=-0.53; 95%CI=-0.97--0.09; p=0.019). 
Discussion and Conclusions: Home telemonitoring appears to have a positive effect in 
reducing respiratory exacerbations and hospitalisations and improving quality of life. 
However, the evidence of its benefits is still limited and further research is needed to 
assess the effectiveness of home telemonitoring in COPD management, as there are still 
few studies in this area. 
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Review Criteria 
Medline, Embase, B-on and Web of Science databases were searched (from June to 
August 2012, updated up until July 2013) for randomised and non-randomised controlled 
trials evaluating the impact of home telemonitoring interventions on healthcare utilisation 
and health-related outcomes of patients with COPD. Meta-analyses were performed, 
when appropriate. 
 
Message for the Clinic 
Home telemonitoring is an innovative approach which enables the management of 
patients’ health condition at home, by exchanging health-related information with 
healthcare professionals. Studies included in this review provided limited evidence for 
the effectiveness of home telemonitoring in COPD on healthcare utilisation and health-
related outcomes. To advocate the use of home telemonitoring as a patient management 
approach and to incorporate it into practice, further work needs to be conducted. 
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Introduction 
Chronic obstructive pulmonary disease (COPD) is a progressive disease which accounts 
for a great economic and social burden [1]. In the United States, COPD was considered 
the 2nd cause of disability-adjusted life-years (DALYs) and the 5th cause of mortality in 
2010 [2]. The disease trajectory is characterised by increasing symptoms (e.g., dyspnoea, 
fatigue) and a progressive decline in health status, punctuated by acute respiratory 
exacerbations [3]. Previous studies have shown that COPD exacerbations have a negative 
impact on patient prognosis [4] and are responsible for the greatest proportion of the total 
direct costs attributable to COPD [5]. Therefore, interventions to manage exacerbations at 
an early stage are urgently needed to reduce morbidity and mortality of COPD 
population, thereby reducing healthcare utilisation and associated costs. 
In recent years, researchers and policy makers have been seeking cost-effective strategies 
for delivering sustainable care in COPD. One promising approach is the use of 
information and communication technologies to monitor patients’ health status while they 
are at home, also referred to as home telemonitoring [6]. Home telemonitoring allows 
healthcare providers to review patients’ clinical data (e.g., oxygen saturation, heart rate) 
more regularly and, thus, health deterioration can be quickly detected and addressed. This 
may lead to improved clinical outcomes, greater patient self-management and less costly 
interventions [7]. 
While the interest in telemonitoring interventions to manage patients at home is 
increasing, the evidence to support its effectiveness is still limited [7]. Previous 
systematic reviews failed to demonstrate the benefit of home telemonitoring in COPD [6, 
8-10]. However, these reviews evaluated studies using home telemonitoring and a 
different telehealth approach, such as telephone support [9, 10] or teleconsultations with 
occasional monitoring of patients’ clinical data [6, 8, 10], rendering the interpretation of 
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the impact of telemonitoring alone. Therefore, the question of whether home 
telemonitoring achieves its purpose, i.e., if it reduces healthcare utilisation and costs by 
effectively detecting and responding to COPD exacerbations in a timely manner, remains 
unanswered. This systematic review aimed to assess the effectiveness of home 
telemonitoring to reduce healthcare utilisation and improve health-related outcomes of 
patients with COPD. 
 
Methods 
Information sources and search strategy 
An electronic literature search was performed from June to August of 2012 in Medline, 
Embase, B-on Online Knowledge Library and Web of Knowledge databases. Search 
terms were based on a combination of the following keywords: [tele(-)monitoring or 
tele(-)health or tele(-)homecare or tele(-)care or tele-home health or home monitoring] 
and [Chronic Obstructive Pulmonary Disease or COPD]. Additional studies were 
searched within the reference list of the included articles, review articles on the topic [6, 
8-12] and weekly automatic updates retrieved from the databases until July 2013. 
 
Eligibility criteria and study selection 
This systematic review was reported according to preferred reporting items for systematic 
reviews and meta-analyses (PRISMA) guidelines [13]. Eligible studies were randomised 
(RCT) and non-randomised controlled trials (NRCT) involving patients with COPD and 
comparing a home telemonitoring intervention (experimental group – HTMG) to usual 
care (control group - CG). Patients in the HTMG had to periodically record clinical data 
(e.g., oxygen saturation, heart rate, symptoms) in their homes and transmit the data on a 
regular basis (i.e., ≥5days/week) using information and communication technologies, for 
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further assessment by a healthcare team. The outcomes of interest were healthcare 
utilisation (i.e., hospitalisations, length of hospital stay, emergency department visits) and 
associated costs, mortality rates, respiratory exacerbations and health-related quality of 
life (HRQOL), collected during or immediately after the intervention.  
Studies were excluded if they: i) included patients with diseases other than COPD; ii) 
included only regular telephone calls, video-consultation or teleconference interventions 
with infrequent transmission of clinical data; iii) involved downloading the data during 
healthcare visits or just at the end of the study; iv) provided telemonitoring in other places 
than patients’ home; v) did not include a group without home telemonitoring (i.e., a CG); 
vi) did not collect the outcomes of interest during or immediately after the intervention. 
Studies with a different design (e.g., one group pretest-posttest, observational or case 
studies), review papers, abstracts, papers on conference proceedings, editorials, 
commentaries to articles and study protocols were excluded. Papers without abstracts or 
written in languages other than English, Portuguese and Spanish were also excluded.  
Initial screening of articles was based on type of publication and relevance for the scope 
of the review, according to their title and abstract. Then, the full-text of potentially 
relevant articles was screened for content to decide its inclusion. Studies with multiple 
publications were identified to avoid duplicate reports.  
 
Data collection 
One reviewer (JC) extracted the data from the included studies and a second reviewer 
(AM) checked the extracted data. Disagreements were resolved by consensus. If 
consensus could not be reached, a third reviewer (DB) was consulted. A structured data 
extraction was performed, focusing on: study design, country where the study was 
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conducted, sample size, type of intervention (HTMG) and comparator (CG), 
telemonitoring duration, outcome measures and results. 
 
Quality assessment 
The quality of the studies was independently assessed by two raters (JC and AM) using a 
modified version of the scoring system developed to evaluate telemedicine research by 
Hailey and co-workers [14], summarised in Polisena et al. [10]. It consists of 5 levels, 
from A (high quality) to E (poor quality), based on study design and performance. Inter-
rater agreement was assessed using Cohen’s kappa coefficient, considering the cut-off 
points [15]: slight agreement (≤0.20), fair agreement (0.21–0.40), moderate agreement 
(0.41–0.60), substantial agreement (0.61–0.80) and almost perfect agreement (≥0.81). 
Disagreements between raters were resolved by consensus.  
 
Synthesis of results 
Meta-analyses were conducted to evaluate the effects of home telemonitoring in 
healthcare utilisation and associated costs, mortality rates, respiratory exacerbations and 
HRQOL. In case of missing data, the corresponding authors were contacted via e-mail to 
provide more information. Five authors [16-20] were contacted; however, only one 
replied. Effect sizes were calculated with the risk ratio (RR) for dichotomous variables 
and the standardised mean difference (SMD) for continuous variables. The 95% 
confidence intervals (95%CI) and significance tests were also computed (statistical 
significance: p<0.05). Effect size data were synthesised into forest plots and a fixed-
models effect was used in the absence of substantial heterogeneity across studies. 
Heterogeneity was measured using the I2 test, which represents the percentage of the 
variation in effect sizes that is due to heterogeneity rather than sampling error [21]. When 
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substantial heterogeneity was found (I2≥50%) [22], a random-effects model was applied. 
If appropriate, subgroup analyses for study design, COPD severity and telemonitoring 
duration were also conducted to explore reasons for heterogeneity. Publication bias was 
assessed by visual inspection of funnel plots and Egger’s regression intercept test if more 
than 5 studies were included in the meta-analysis [23]. Quantitative analyses were 
performed using Comprehensive Meta-Analysis software v2.0 (Biostat, Englewood, New 
Jersey). 
 
Results 
Study selection 
The literature search identified 455 records. After duplicates removed, 130 records were 
screened for content through title and abstract. From these, 114 were excluded. The full-
text of 16 articles was then assessed for eligibility and 11 articles were excluded (Figure 
1). Five articles were identified as relevant from the automatic updates of the databases 
and the reference lists and were included in the review. One study had 2 publications 
reporting healthcare utilisation [18] and health-related outcomes [24], thus both articles 
were considered. In total, 10 articles on 9 studies were included, all published in English: 
7 RCTs [16-18, 20, 24-27] and 2 NRCTs [19, 28]. 
(Insert Figure 1) 
 
Quality assessment 
Two articles were rated as A (high quality) [18, 26], 7 as B (good quality) [17, 19, 20, 24, 
25, 27, 28] and 1 as C (fair to good quality) [16]. Two articles rated as good quality were 
in the borderline to be considered as high quality [24, 25]. Cohen’s kappa coefficient 
revealed substantial agreement between raters (κ=0.63; p=0.036). 
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Study characteristics 
Five studies were published from 2011 to the present [16, 20, 25-27]. Table 1 provides an 
overview of the characteristics of each study.  
(Insert Table 1) 
COPD severity was an inclusion criterion in all studies. Patients had to present moderate 
to severe COPD (n=4) [18, 20, 24-26], severe COPD (n=2) [19], severe to very severe 
COPD (n=5) [17, 27, 28] and/or receive oxygen therapy (n=1) [16, 27]. Samples included 
varied from 30 [19] to 165 [28], mostly older people (mean age≥65 years old).  
Telemonitoring data were generally transmitted to a monitoring centre on a daily basis, 
during 2 [26] to 12 [25] months. Patients’ compliance with data transmission was 
assessed in 5 studies [18, 20, 25-27] and ranged from 40% [25] to 98% [26], depending 
on the clinical measurement. In all studies, patient’s readings outside pre-determined 
values triggered an immediate action from the healthcare team monitoring the data. Usual 
care included the same healthcare component provided to the HTMG, but without 
telemonitoring (Table 1). 
 
Synthesis of results 
An overview of the outcomes assessed in each study is provided in Table 2. 
 (Insert Table 2) 
 Hospitalisation rates 
Six RCTs [16, 17, 20, 24, 26, 27] and 2 NRCTs [19, 28] including 486 patients reported 
hospitalisation rates in both groups. Patients receiving home telemonitoring had a 
significantly lower risk of hospitalisation than those receiving usual care (RR=0.72; 
95%CI=0.53-0.98; Z=-2.12; p=0.034; Figure 2; I2=4.73%). Publication bias was not 
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evident either from visual inspection of the funnel plot (data not shown) and the Egger’s 
regression intercept test (intercept=-0.21; 95%CI=-2.46-2.03; p=0.824).    
(Insert Figure 2) 
 
 Mean number of hospitalisations 
Seven studies reported the mean number of hospitalisations per patient [16, 17, 19, 24, 
25, 27, 28]. Three studies were excluded from quantitative analysis due to missing data 
[16, 17, 19]. Therefore, 4 studies including 244 patients with COPD were included [24, 
25, 27, 28]. There were no significant differences between groups (SMD=-0.06; 95%CI=-
0.32-0.19; Z=-0.50; p=0.617; I2=16.42%). 
 
 Length of hospital stay 
Eight studies providing information about hospitalisations also reported the mean length 
of hospital stay (in days) [16, 18-20, 25-28]. Four studies were excluded from the 
quantitative analysis due to missing or non-comparable data [16, 18-20]. Four studies 
with 244 patients with COPD were included [25-28]. The length of hospital stay was not 
different between groups (SMD=0.06; 95%CI=-0.19-0.31; Z=0.48; p=0.635; I2=0%). 
 
 Emergency department visit rates 
Only 4 studies with 194 patients, all RCTs, reported emergency department visit rates 
[16, 17, 26, 27]. There was no evidence of a significant effect of home telemonitoring on 
emergency department visit rates (RR=0.68; 95%CI=0.38-1.18; Z=-1.34; p=0.179; 
I2=22.53%).  
 
 Mean number of emergency department visits 
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Five studies reported the mean number of emergency department visits [16-18, 27, 28]. 
Three studies were excluded from the quantitative analysis due to non-comparable data 
[16-18]. Two studies, 1 RCT [27] and 1 NRCT [28], comparing home telemonitoring to 
usual care for 4-6 months in 160 patients with severe to very severe COPD were 
included. The number of emergency department visits was not significantly different 
between groups (SMD=0.20; 95%CI=-0.49-0.88; Z=0.56; p=0.576). There was 
substantial heterogeneity across studies (I2=74.81%) [22], therefore, a random-effects 
model was applied and a subgroup analysis of study designs was conducted.  
The NRCT [28] reported a significantly lower mean number of emergency department 
visits in the HTMG (SMD=0.51; 95%CI=0.14-0.88; Z=2.70; p=0.007). This positive 
trend was not observed in the RCT [27] (SMD=-0.19; 95%CI=-0.78-0.39; Z=-0.65; 
p=0.515).  
 
Healthcare-related costs 
Three studies assessed the costs related to healthcare services [16, 17, 19]. De San Miguel 
et al. [16] reported total cost savings of 112,439US dollars (USD) in the HTMG. Koff et 
al. [17] suggested that home telemonitoring reduced healthcare-related costs (mean 
change=-1,401USD; 95%CI=-6,566-3,764USD) when compared to usual care (mean 
change=1,709USD; 95%CI=-4,349-7,768USD); however, the difference was not 
significant (p=0.21). Paré et al. [19] found that telemonitoring yielded a reduction in 
hospitalisation costs (29,686USD) and a total cost reduction of 6,750USD when 
compared to usual care, including the costs associated with the implementation of each 
intervention (e.g., home visits or technology).  
 
Mortality rates 
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Four studies with 294 patients presented mortality rates [18, 25, 27, 28]. Two of them 
reported non-COPD related reasons for death [18, 25]. Mortality rates were not different 
between groups (RR=1.43; 95%CI=0.40-5.03; Z=0.55; p=0.582; I2=0%). 
 
Respiratory exacerbations 
One RCT [20] and 1 NRCT [28] including 214 patients assessed the number of 
respiratory exacerbations during the intervention in both groups. These studies found that 
the CG had a higher incidence of respiratory events (HTMG:9/50; CG:15/49; p=0.152) 
[20] and mean number of exacerbations (HTMG=0.65±1.4; CG=1.01±1.4; p=0.004) [28]. 
Two studies reported the number of exacerbations detected by the telemonitoring system 
in the HTMG [17, 27]. In Jódar-Sánchez et al. [27] the device provided 40 alerts and in 
Koff et al. [17] it detected 9 exacerbations. A worsening of peripheral oxygen saturation 
was the most frequent altered clinical finding in the detection of a respiratory 
exacerbation [17, 20]. 
 
Health-related quality of life 
Seven studies evaluated patients’ HRQOL before/after the intervention, using either 
disease-specific (Chronic Respiratory Disease Questionnaire [25], Chronic Respiratory 
Questionnaire [16, 26], St. George’s Respiratory Questionnaire (SGRQ) [17, 24, 27], 
Clinical COPD Questionnaire [28]) or general (EURO-QOL-5D Questionnaire [24, 27], 
Medical Outcome Study Short-Form 36 Questionnaire[25]) quality of life measurement 
instruments. Overall, no significant differences were found between groups. Pooling was 
not appropriate because the instruments measure different domains of HRQOL [29]. Only 
two RCTs presenting the mean change (i.e., posttest-pretest) of total and sub-dimension 
scores of the SGRQ were pooled [17, 27]. In SGRQ, lower scores represent better quality 
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of life [30]. A statistically significant change was found in the SGRQ total score (SMD=-
0.53; 95%CI=-0.97- -0.09; Z=-2.35; p=0.019; I2=17.74%) suggesting that patients 
receiving home telemonitoring had a greater HRQOL after the intervention (Figure 3). 
This trend was not confirmed for SGRQ sub-dimensions (p>0.05; I2=0.00%). 
In terms of clinical significance (i.e., mean change≥4units) [30], both groups exhibited a 
clinically important change in SGRQ total score in Jódar-Sánchez et al. [27] 
(HTMG=10.9; CG=4.5); however, only the HTMG achieved this clinical change in Koff 
et al. [17]. 
(Insert Figure 3) 
 
Discussion 
This systematic review assessed the effectiveness of home telemonitoring in COPD. Nine 
studies were included, five of them published from 2011 to the present which emphasises 
the novelty of this type of intervention. Most studies were RCTs of good quality; 
however, some of them had relatively small samples. Findings suggest that, although 
home telemonitoring appears to have a positive effect in detecting and reducing 
respiratory exacerbations and improving HRQOL, there is still no clear indication that it 
reduces healthcare utilisation and associated costs as only hospitalisation risk was 
reduced in the HTMG. One NRCT [28] also showed a significantly lower number of 
emergency department visits in the HTMG. However, this result should be interpreted 
with caution because of the inherent risk of bias associated with this study design. 
Furthermore, this positive trend was not observed in a RCT with a similar target-
population and telemonitoring duration [27]. 
Healthcare utilisation was similar in both groups, with the exception of hospitalisation 
rates. Some reasons may have contributed to these findings. Firstly, it was not always 
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clear whether healthcare utilisation reported in some studies was related to respiratory 
exacerbations [19, 27, 28, 31]. Therefore, it is unclear if COPD-related healthcare 
utilisation was actually reduced. Secondly, the levels of patients’ compliance with 
telemonitoring may also explain some of the results. As reported earlier, compliance with 
data transmission ranged from 40% [25] to 98% [26]. This lower compliance found in 
some studies might have contributed to the failure in detecting health deterioration. 
Hence, the purpose of home telemonitoring, i.e., the continuous monitoring of patients’ 
clinical data to early detect and address health deterioration, may not have been reached 
due to a lack of patients’ compliance.  
The two studies reporting the occurrence of respiratory exacerbations in both groups 
found that the CG had a higher number of exacerbations during the intervention, when 
compared to the HTMG [20, 28]. Two additional studies reported that the telemonitoring 
system was able to detect respiratory exacerbations [17, 27]. These findings support the 
hypothesis that telemonitoring can be a potential way of detecting and managing COPD 
exacerbations in a timely manner. Advancements in physiological sensors and in 
information and communication technologies may, therefore, offer opportunities for 
providing healthcare management tools, enabling extended independent living at home 
for individuals with COPD. However, there is still a lack of clarity about which 
parameters should be used to detect exacerbations [7]. The worsening of peripheral 
oxygen saturation was the most frequent altered clinical finding in the detection of 
respiratory exacerbations [17, 20]. A previous exploratory research supports these results 
[32]. According to Hurst and co-workers [32], a composite measure that combines 
oxygen saturation and heart rate may be useful to identify an exacerbation onset. In this 
review, only four of the eight studies collected both measurements [18, 20, 24, 26, 27]. 
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Studies reporting healthcare-related costs revealed a positive trend towards 
telemonitoring interventions, suggesting that home telemonitoring may, therefore, have 
the ability to produce savings in COPD management [11]. This trend may be in part 
related to the decreased hospitalisation rates found in the present study. According to 
previous research, hospitalisations represent more than one-half of the total direct costs 
attributable to COPD [33], mostly due to respiratory exacerbations [34]. However, the 
small number of studies providing healthcare-related cost information and the differences 
in the estimation of this outcome (e.g., in the study of De San Miguel et al. [16], hospital 
visit costs were based on length of stay rather than number of hospitalisations) limit the 
interpretation of the findings. Further work still needs to be conducted on this topic to 
draw final conclusions. 
Findings on patients’ HRQOL were inconsistent. In most studies, no significant changes 
after the intervention were found. Nevertheless, they used different measurement 
instruments which made difficult to perform comparisons. When two studies using the 
same questionnaire were pooled [17, 27], significant changes were found in favour of the 
HTMG. These studies also demonstrated a clinically important change in the HTMG and 
one found a clinical change also in the CG [27]. Hence, the ability of home 
telemonitoring to demonstrate an improvement in HRQOL beyond to that achieved with 
usual care remains a challenge. 
 
Limitations 
One limitation of this review concerns the exclusion of six studies written in languages 
other than English, Portuguese and Spanish, since they could be relevant for the scope of 
the review. The fact that some studies could not be integrated in the quantitative analysis 
due to missing or non-comparable data is another limitation. Thus, it is unknown if any of 
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these studies could have influenced the outcomes in the telemonitoring group. Lastly, in 
most cases, the number of studies included in the meta-analysis was insufficient (n<5) 
[23] to measure the potential of publication bias. 
 
Implications for research and practice 
The value of home telemonitoring to reduce healthcare utilisation and improve health-
related outcomes is not yet well defined. Therefore, to advocate the use of this 
intervention as a patient management approach and to incorporate it into practice, further 
work needs to be conducted. In addition, variations in compliance rates suggest that 
telemonitoring regimens may not be appropriate for all patients. Further research is 
needed to identify the types of patients most likely to benefit from these interventions. 
Future studies should also consider: i) including a composite measure of oxygen 
saturation and heart rate to early detect exacerbations; ii) using similar HRQOL 
measurement instruments to enable comparisons across studies; iii) reporting healthcare 
utilisation data in a format that can be further pooled into meta-analysis.  
 
Conclusion 
The findings provide limited evidence of the effectiveness of home telemonitoring to 
reduce healthcare utilisation and improve health-related outcomes in patients with COPD. 
Although this intervention appears to have a positive effect in reducing respiratory 
exacerbations and hospitalisations and improving HRQOL, there is still no clear 
indication that it reduces healthcare utilisation and associated costs. Further research is 
needed to assess the effectiveness of home telemonitoring in COPD management, as 
there are still few studies in this area. 
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Figure 1 – Flow diagram for study selection. 
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Figure 2 – Risk ratio of hospitalisation in the home telemonitoring and control groups 
(fixed-effects model).  
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Figure 3 – Mean change in quality of life of the experimental and control groups using 
the St. George’s Respiratory Questionnaire total and sub-dimension (activity, impact 
and symptoms) scores (fixed-effects model). Std diff in means: standardised mean 
difference. 
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Table 1 - Main characteristics of the studies. 
First author 
(year) 
Study 
design 
Country Participants Telemonitoring 
duration 
Home telemonitoring 
(experimental group) 
Usual care  
(experimental and control 
groups) 
Antoniades 
(2012) [25] 
RCT Australia 44 patients with moderate to 
severe COPD and with ≥1 
hospitalisations/year:  
HTMG (n=22) and CG (n=22).  
12 months Transmission of data about 
spirometry parameters, weight, 
temperature, blood pressure, 
oxygen saturation, 
electrocardiogram, sputum 
colour and volume, symptoms 
and medication usage, on a daily 
basis (on weekdays).  
Clinical management according 
to Australian and New Zealand 
guidelines with provision of 
outreach nursing, a written 
action plan and availability of 
pulmonary rehabilitation 
(chronic disease management 
programme). 
Chau (2012) 
[26] 
RCT Hong 
Kong 
53 older people with moderate 
to severe COPD and with ≥1 
hospitalisations/year:  
HTMG (n=30) and CG (n=23). 
2 months (mean 
duration 54.36 
days) 
Measurements of oxygen 
saturation, heart rate and 
respiration rate 3 times a day (on 
weekdays). The technology 
In-home nurse visits to offer 
education on self-care and 
symptom management 
techniques. 
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provided patients with a 
medication and pursed-lips 
breathing reminder with a 
feedback function. 
Jódar-Sánchez, 
(2013) [27] 
RCT Spain 45 patients with clinically stable 
COPD and chronic respiratory 
failure, receiving long-term 
oxygen therapy and with ≥1 
hospitalisations/year:  
HTMG (n=24); CG (n=21). 
4 months Daily measurement (on 
weekdays) of blood pressure, 
heart rate and oxygen saturation 
and spirometry 2 days per week, 
20 minutes after taking 
prescribed inhaled therapy, 
seated and rested, and while on 
oxygen therapy. 
Conventional medical care. 
Koff (2009) [17] RCT United 
States of 
America 
40 patients with severe to very 
severe COPD (GOLD 3 and 
GOLD 4):[3]  
HTMG (n=20) and CG (n=20). 
3 months Transmission of data about 
symptoms, oxygen saturation, 
spirometry parameters and steps 
in six-minute walking distance, 
Usual access to healthcare 
providers.  
HOME TELEMONITORING IN COPD 
28 
 
on a daily basis (on weekdays), 
plus disease-specific and self-
management education and 
interaction with study 
coordinators through the 
telemonitoring system 
(proactive integrated care 
programme). 
Lewis (2010a) 
[24], (2010b) 
[18] 
RCT United 
Kingdom 
40 patients with moderate to 
severe COPD after undertaken 
pulmonary rehabilitation:  
HTMG (n=20) and CG (n=20). 
6 months Data transmission twice a day 
regarding the condition of 
patients’ chest over the 
preceding day/night, oral 
temperature, heart rate and 
oxygen saturation. 
Standard care. 
Paré (2006) [19] NRCT Canada 30 patients with severe COPD 
that required frequent home 
6 months Daily transmission of peak flow 
rate, symptoms and medication 
Traditional system of in-home 
visits (control group only). 
HOME TELEMONITORING IN COPD 
29 
 
visits:  
HTMG (n=20) and CG (n=10). 
taken. 
Pedone (2013) 
[20] 
RCT Italy 99 older people with moderate 
to severe COPD (GOLD 2 and 
GOLD 3):[3]  
HTMG (n=50) and CG (n=49). 
9 months Data transmission 5 times a day, 
every 3 hours, of oxygen 
saturation, heart rate, respiratory 
rate, physical activity and body 
temperature. 
 
Standard care. 
De San Miguel 
(2013) [16] 
RCT Australia 71 patients with COPD treated 
with long-term oxygen therapy:  
HTMG (n=36); CG (n=35). 
6 months Daily transmission of blood 
pressure, heart rate, oxygen 
saturation, weight, temperature 
and of data related to patients’ 
general state of health. Patients 
also received an educational 
book about COPD. 
Educational book about COPD. 
Trappenburg NRCT Netherlan 165 patients with severe to very 6 months Daily transmission of data about Usual access to healthcare 
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(2008) [28] ds severe COPD (GOLD 3 and 
GOLD 4)[3] with ≥1 
hospitalisations/6 months: 
HTMG (n=101) and CG (n=64). 
symptoms, medication 
compliance and knowledge, 
with immediate feedback from 
the system. 
providers. 
COPD – chronic obstructive pulmonary disease; CG – control group; HTMG – home telemonitoring group; GOLD - Global Initiative for Chronic 
Obstructive Lung Disease; NRCT - non-randomised controlled trial; RCT – randomised controlled trial. 
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Table 2 - Types of outcomes measured in the home telemonitoring and control groups. 
 Hospitalisations 
Length of 
hospital 
stay 
Emergency 
department visits 
Healthcare 
costs 
Mortality 
Quality of 
life 
Respiratory 
exacerbations 
Other 
outcomes* 
First author 
(year) 
Rate Mean Mean Rate Mean Mean Rate Mean Rate Mean  
Antoniades 
(2012) [25] 
 ● ●    ● ●    
Chau (2012) 
[26] 
●  ● ●    ●   ● 
Jódar-
Sánchez, 
(2013) [27] 
● ● ● ● ●  ● ●   ● 
Koff (2009)  
[17] 
●   ●  ●  ●    
Lewis (2010a) ● ● ●  ●  ● ●   ● 
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[24], (2010b) 
[18] 
Paré (2006) 
[19] 
● ● ●   ●     ● 
Pedone (2013) 
[20] 
●  ●      ●   
De San 
Miguel (2013) 
[16] 
● ● ● ● ● ●  ●   ● 
Trappenburg 
(2008) [28] 
● ● ●  ●  ● ●  ● ● 
*Other outcomes: forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC) and FEV1/FVC ratio [26], type and quantity of prescribed 
medication [28], six-minute walking distance [25], anxiety and depression symptoms [24], primary care contacts (chest and non-chest) [18], specialised 
consultations [27], healthcare team phone calls and home visits [16-19, 27], mortality [18, 27] and costs related to telemonitoring equipment and healthcare 
resources [19]. 
 
 
